Company: PCRX
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001396814-25-000102
Chunk: 178

Company: Pacira BioSciences, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 178
---
 diluted net (loss) income per common share calculation as if the Company had converted the convertible senior notes on the first day of each period presented. Adjustments to the numerator are made to add back the interest expense associated with the convertible senior notes on a post-tax basis. Adjustments to the denominator reflect the number of shares assumed to be convertible at the beginning of the period.

Pacira BioSciences, Inc.  |  Q2 2025 Form 10-Q  |  Page 29

Potential common shares are excluded from the diluted net (loss) income per common share computation to the extent they would be antidilutive. The following table sets forth the computation of basic and diluted net (loss) income per common share for the three and six months ended June 30, 2025 and 2024 (in thousands, except per common share amounts):Three Months EndedJune 30,Six Months EndedJune 30,2025202420252024Numerator:   Net (loss) income—basic$(4,847)$18,886 $(35)$27,865 2025 Notes if-converted method adjustment— 762 — 1,790    Adjusted net (loss) income—diluted$(4,847)$19,648 $(35)$29,655 Denominator:   Weighted average common shares outstanding—basic45,459 46,174 45,867 46,337 Computation of diluted securities:2025 Notes if-converted method adjustment— 4,122 — 4,865    Dilutive effect of RSUs— 239 — 162 Dilutive effect of ESPP share options— 4 — 2    Weighted average common shares outstanding—diluted45,459 50,539 45,867 51,366 Net income per common share:   Basic net (loss) income per common share$(0.11)$0.41 $(0.00)$0.60    Diluted net (loss) income per common share$(0.11)$0.39 $(0.00)$0.58 The following table summarizes the outstanding stock options, RSUs, ESPP share options and convertible senior notes that were excluded from the diluted net (loss) income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):Three Months EndedJune 30,S